Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Gerlinger Marco, Rowan Andrew J, Horswell Stuart, Math M, Larkin James, Endesfelder David, Gronroos Eva, Martinez Pierre, Matthews Nicholas, Stewart Aengus, Tarpey Patrick, Varela Ignacio, Phillimore Benjamin, Begum Sharmin, McDonald Neil Q, Butler Adam, Jones David, Raine Keiran, Latimer Calli, Santos Claudio R, Nohadani Mahrokh, Eklund Aron C, Spencer-Dene Bradley, Clark Graham, Pickering Lisa, Stamp Gordon, Gore Martin, Szallasi Zoltan, Downward Julian, Futreal P Andrew, Swanton Charles

The New England journal of medicine · 2012 · PMID 22397650 · 인용 8.5k

PubMed ↗DOI ↗

BACKGROUND: Intratumor heterogeneity may foster tumor evolution and adaptation and hinder personalized-medicine strategies that depend on results from single tumor-biopsy samples.

METHODS: To examine intratumor heterogeneity, we performed exome sequencing, chromosome aberration analysis, and ploidy profiling on multiple spatially separated samples obtained from primary renal carcinomas and associated metastatic sites. We characterized the consequences of intratumor heterogeneity using immunohistochemical analysis, mutation functional analysis, and profiling of messenger RNA expression.

RESULTS: Phylogenetic reconstruction revealed branched evolutionary tumor growth, with 63 to 69% of all somatic mutations not detectable across every tumor region. Intratumor heterogeneity was observed for a mutation within an autoinhibitory domain of the mammalian target of rapamycin (mTOR) kinase, correlating with S6 and 4EBP phosphorylation in vivo and constitutive activation of mTOR kinase activity in vitro. Mutational intratumor heterogeneity was seen for multiple tumor-suppressor genes converging on loss of function; SETD2, PTEN, and KDM5C underwent multiple distinct and spatially separated inactivating mutations within a single tumor, suggesting convergent phenotypic evolution. Gene-expression signatures of good and poor prognosis were detected in different regions of the same tumor. Allelic composition and ploidy profiling analysis revealed extensive intratumor heterogeneity, with 26 of 30 tumor samples from four tumors harboring divergent allelic-imbalance profiles and with ploidy heterogeneity in two of four tumors.

CONCLUSIONS: Intratumor heterogeneity can lead to underestimation of the tumor genomics landscape portrayed from single tumor-biopsy samples and may present major challenges to personalized-medicine and biomarker development. Intratumor heterogeneity, associated with heterogeneous protein function, may foster tumor adaptation and therapeutic failure through Darwinian selection. (Funded by the Medical Research Council and others.).

🏛️ 거인의 어깨이 분야를 만든 논문들

종양 내 유전적 다양성과 분지형 진화 과정을 다중 지역 시퀀싱을 통해 규명했습니다.

이야기를 쓰는 중…